Kriti Nutrients Q3 FY26: Income ₹226 cr, PAT ₹9.21 cr

What Kriti Nutrients reported for Q3 FY26

Kriti Nutrients Ltd reported its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. Total income from operations for Q3 FY26 stood at ₹226.21 crore, compared with ₹175.41 crore in Q3 FY25. Net profit after tax (PAT) for the quarter came in at ₹9.21 crore, while earnings per share (EPS) improved to ₹1.84.

The company also disclosed that the results were reviewed by the Audit Committee on February 4, 2026. The Board of Directors took the results on record in a meeting held on February 5, 2026.

Board meeting and regulatory steps

The company had scheduled its board meeting for February 5, 2026 at its Indore corporate office to consider and approve the Q3 FY26 unaudited standalone and consolidated financial results. The agenda also included taking on record the auditors’ limited review report and other general business matters.

Kriti Nutrients indicated it would file the corporate announcement in XBRL format within the stipulated timeframe and host the information on its official website.

Q3 FY26 vs Q3 FY25: headline numbers

On a standalone basis, the company reported net profit before tax of ₹11.85 crore in Q3 FY26, compared with ₹12.01 crore in Q3 FY25. PAT for Q3 FY26 was ₹9.21 crore, compared with ₹8.25 crore in Q3 FY25. Basic EPS improved to ₹1.84 from ₹1.65.

On a consolidated basis, Q3 FY26 total income from operations was also reported at ₹226.21 crore, and PAT was ₹9.16 crore.

Nine-month performance through December 2025

For the nine-month period ended December 31, 2025, Kriti Nutrients reported total income of ₹672.65 crore and net profit of ₹27.65 crore. The company also disclosed total comprehensive income of ₹27.63 crore on a standalone basis for the nine-month period.

For the nine months, both basic and diluted EPS were reported at ₹5.52, reflecting the company’s reported per-share performance over the period.

Quarterly operating picture from the published table

The quarterly table shared by the company shows net sales moving up from ₹172.92 crore in Dec 2024 to ₹224.31 crore in Dec 2025, with operating profit remaining in the range of about ₹6.09 crore to ₹11.51 crore over the listed quarters.

FY21 to FY25 trends in revenue and profit

The company’s Profit & Loss data (all figures in crore) shows net sales at ₹734.34 crore in FY25 versus ₹684.36 crore in FY24. Net profit was reported at ₹37.02 crore in FY25, compared with ₹45.29 crore in FY24. Over the same period, profit before tax was ₹49.78 crore in FY25 and ₹60.58 crore in FY24.

The same table shows operating profit at ₹48.03 crore in FY25 and ₹62.22 crore in FY24. Other income increased to ₹7.76 crore in FY25 from ₹4.45 crore in FY24, while interest expense reduced to ₹0.57 crore in FY25 from ₹1.39 crore in FY24.

Consolidated scope, capital base, and reserves

Kriti Nutrients said its consolidated financial statements include the results of associate company Kriti Industries (India) Limited. The company maintained equity share capital of ₹5.01 crore with a face value of ₹1 each.

It also disclosed reserves (excluding revaluation reserve) of ₹206.88 crore as per the audited balance sheet of the previous year, which it described as part of its financial foundation.

Q2 FY26 snapshot and stock trading details cited

Separately, the company’s consolidated results for the period ended September 30, 2025 (Q2 FY26) showed total income of ₹215.35 crore versus ₹231.09 crore in Q1 FY26, and net profit of ₹8.90 crore versus ₹9.49 crore in Q1 FY26. EPS for Q2 FY26 was reported at ₹1.78 versus ₹1.89 in Q1 FY26.

The same cited report stated the stock last traded on BSE at ₹88.17 versus a previous close of ₹87.96, with an intraday high of ₹88.25 and low of ₹87.38.

Key market metrics listed alongside the results

The dataset also listed market capitalization at ₹441 crore and a price-to-earnings ratio (TTM) of 13.65. It showed basic EPS (TTM) at ₹6.43, employees (FY) at 244, and net income (FY) at ₹36.99 crore.

These figures provide additional context on valuation and scale as the company reports sequential quarterly performance.

What to watch next

The company has already completed its Audit Committee review (February 4, 2026) and board consideration (February 5, 2026) for the unaudited Q3 FY26 results. Next updates are expected through the company’s statutory filings, including the XBRL submission and website disclosures referenced in its announcement.